Skip to main content
. 2022 Oct 2;22:300. doi: 10.1186/s12935-022-02725-5

Fig. 3.

Fig. 3

Kaplan–Meier curves for the OS of patients in the high-risk group and low-risk group in the development cohort and the validation cohort: all patients (A, B); stage I/II (C, E); stage III/IV (D, F)